pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·Jul 22·1 min read
save

Webinar Highlights Emerging Recovery in Biopharma Hiring and Talent Strategies for Commercial Growth

Jul 22, 2026·read at BioSpace ↗Positive

The BioSpace webinar "From Clinical to Commercial: Talent Strategies for Biopharma Growth" examined recent hiring activity across the biopharma sector and offered guidance for companies preparing to launch products.

Presenters noted early signs of a modest recovery in the 2026 job market, describing how economic conditions are beginning to ease and how talent acquisition teams can respond to shifting demand for commercial and sales roles.

Margaret Blackwell, Global Head of Talent Acquisition at Amplity, led a data‑driven discussion on hiring trends, emphasizing practical steps for HR and talent professionals to build effective commercial teams as products move toward market launch.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth”

read at BioSpace ↗
706 words · retrieved Jul 22
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PFIZER3ELI LILLY CO2LILLY2SEAGEN2Ultragenyx Pharmaceutical Inc.2ASTRAZENECAGENENTECHJOHNSON & JOHNSONLEADINGNOVARTISUniversity of PennsylvaniaVIATRIS
drugs
Rare Diseaseranibizumabranibizumab biosimilar
topics
Oncology3Ophthalmology3AMD2Rare Disease2

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 1d agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 30These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.BioPharma Dive
  • Dec 23Fierce Biotech Layoff Tracker 2026: Novartis nixes Swiss site; TScan telegraphs 75% headcount dropFierce Biotech